AGIOS PHARMACEUTICALS, INC. Convertible Preferred Stock, Shares Issued upon Conversion
AGIOS PHARMACEUTICALS, INC. (AGIO) had Convertible Preferred Stock, Shares Issued upon Conversion of 19.73 million shares as of 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2015-02-24
- 2014-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 19.73M shares.
- 2013-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 19.73M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2014-12-31 | 19.73M shares 10-K · filed 2015-02-24 |
| 2013-12-31 | 19.73M shares 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |